Consistent with a previous report showing that the NLRP3 inflammasome is activated in patient-derived cell lines and microglia17, we found that the mRNA levels of NLRC4 were significantly elevated in glioma patients (see Supplementary Fig. S1g). This evidence concerns the gene NLRC4 and central nervous system cancer.